ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: However, because CML occurs at a frequency of 1–2 cases per 100,000 per year, a very large cohort would be needed, together with analysis of an equal number of individuals without detectable BCR-ABL1 transcripts.